The Biotechnology Innovation Organization (BIO) will be holding its annual BIO International Convention June 6-9, 2016 in San Francisco, CA. Founded in 1993, BIO is a nonprofit association seeking supportive biotechnology policies on behalf of biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. The BIO International Convention serves to educate the public and policymakers about biotechnology, while fostering partnering meetings and other business development activities to keep the biotech industry growing.
Descriptions of the Convention's 125+ Breakout Sessions and six Super Sessions can be obtained here. Among the sessions that may be of interest to Patent Docs readers are:
Tuesday, June 7
Plenary Session: Overview of Critical Trends Affecting the Innovative Industry (Emerging Opportunities in Global Markets Track) -- 10:45 am to 12:00 pm (Room North 124)
Fireside Chat with Robert Califf, MD, Commissioner, US Food and Drug Administration -- 11:00 am to 12:00 pm (Room West 3011)
Rise of the Biosimilars: Recent Developments and Strategies for Innovators and Biosimilar Applicants for Resolving Patent Disputes Under the BPCIA (Intellectual Property Track) -- 1:00 to 2:00 pm (Room West 3008)
Will the PTAB be a Road Block for Biotech? Lessons Learned from the First Three Years of Inter-Partes Review and Future Prospects (Intellectual Property Track) -- 2:15 to 3:15 pm (Room West 3008) – panel includes Patent Docs author Kevin Noonan
Piecing Together the Hatch-Waxman, BPCIA and PTAB Puzzle: Revealing the Big Picture in Patent Challenges Brought in Multiple Fora (Intellectual Property Track) – 3:30 to 4:30 pm (Room West 3008)
30 Years of Genomics – Bridging the Past with the Future (Personalized Medicine & Diagnostics Track) -- 3:30 to 4:30 pm (Room West 3003)
Wednesday, June 8
Keynote Panel: Who Will be the Next President of the United States? -- 9:00 to 10:30 am (Room Esplanade Ballroom)
US Patents and Global Business: Clear Borders or Blurred Lines? (Intellectual Property Track) -- 10:45 to 11:45 am (Room West 3008)
The Future of Biosimilars: How Will Policy and Market Dynamics Impact Patient Value and Access in the US? (Value, Patient Access, & Commercialization Track) -- 10:45 am to 12:00 pm (Room West 3003)
Building Personalized Medicine Policy: The 21st Century Cures and Healthier Americans Legislative Proposals (Personalized Medicine & Diagnostics Track) -- 1:00 to 2:00 pm (Room West 3005)
Protecting Biomedical Innovation in a Shifting Patent-Eligibility Landscape (Intellectual Property Track) -- 2:15 to 3:15 pm (Room West 3008)
No Patent, No Cure (Intellectual Property Track) -- 3:30 to 4:30 pm (Room West 3008)
Tackling Tough Targets with a New Wave of Antibody Technologies (Next Generation Biotherapeutics Track) -- 3:30 to 4:30 pm (Room West 3001)
Biosimilar Medicines: Creating Sustainable Competition in an Era of a New Patent Cliff in Biological Medicines (Value, Patient Access, & Commercialization Track) -- 3:30 to 4:30 pm (Room West 3003)
Intellectual Property Track Reception (Intellectual Property Track) -- 4:30 to 5:30 pm (Room West Third Floor Lobby Intellectual Property Reception)
Thursday, June 9
TPP and Beyond: How Global Trade Agreements are Changing the Rules for Biologics and Biotech Products (Emerging Opportunities in Global Markets Track) -- 9:00 to 10:15 am (Room North 124)
Gene Therapy or CRISPR: Which One Will Change the Future of Medical Care? (Next Generation Biotherapeutics Track) -- 9:00 to 10:15 am (Room West 3001)
Get Your WorldView On: 2016 Scientific American Biotech Scorecard (Special Program) -- 10:30 to 11:30 am (Room North 124)
Living Therapeutics: Harnessing the Microbiome (Next Generation Biotherapeutics Track) -- 10:30 to 11:30 am (Room West 3001)
Companion Diagnostics: The Evolving Need for Progressive Partnerships Between Pharma and Diagnostics Companies (Personalized Medicine & Diagnostics Track) -- 10:30 to 11:30 am (Room West 3005)
As part of the Convention, more than 1,800 biotech companies, organizations, and institutions will participate in the BIO Exhibition. A searchable list of exhibitors can be found here. Information regarding registration and pricing can be obtained here. Patent Docs authors Donald Zuhn, Kevin Noonan, and Andrew Williams, and Patent Docs contributors Sherri Oslick, James DeGiulio, Nate Chongsiriwatana, Josh Rich, and Grant Drutchas will be attending BIO as part of the MBHB contingent, and will be reporting on a few of the sessions listed above. Patent Docs readers who may be attending BIO are encouraged to stop by the MBHB booth (#504).
In addition, the Docs will be attending the MBHB reception at Kells Irish Pub (530 Jackson Street, San Francisco) on Tuesday, June 7 from 8:00 pm to 1:00 am. Additional information about the reception, including invitations for the event, can be picked up at the MBHB booth.
Comments